XY101
CAS No. 2349368-16-5
XY101 ( —— )
Catalog No. M26510 CAS No. 2349368-16-5
XY101 is a selective, metabolically stable and orally available agonist of RORγ inverse(IC50 of 30 nM and a Kd of 380 nM).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 260 | Get Quote |
|
10MG | 447 | Get Quote |
|
25MG | 714 | Get Quote |
|
50MG | 1017 | Get Quote |
|
100MG | 1368 | Get Quote |
|
500MG | 2673 | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameXY101
-
NoteResearch use only, not for human use.
-
Brief DescriptionXY101 is a selective, metabolically stable and orally available agonist of RORγ inverse(IC50 of 30 nM and a Kd of 380 nM).
-
DescriptionXY101 is a selective, metabolically stable and orally available agonist of RORγ inverse(IC50 of 30 nM and a Kd of 380 nM).(In Vitro):XY101 effectively inhibits cell growth, colony formation and expression of androgen receptor (AR), AR-V7 and prostate specific antigen (PSA).(In Vivo):XY101 exhibits significant antitumor activities during the treatment period with tumor growth inhibition and is well tolerated without obvious body weight loss.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptorα-synuclein
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2349368-16-5
-
Formula Weight563.5
-
Molecular FormulaC25H20F7NO4S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCCS(=O)(=O)c1ccc(CC(=O)Nc2ccc(cc2)-c2ccc(cc2F)C(O)(C(F)(F)F)C(F)(F)F)cc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Pujols J, et al. Small molecule inhibits α-synuclein aggregation, disrupts amyloid fibrils, and prevents degeneration of dopaminergic neurons. Proc Natl Acad Sci U S A. 2018 Oct 9;115(41):10481-10486.
molnova catalog
related products
-
Mal-amido-PEG7-acid
Mal-amido-PEG7-acid is a PEG-based PROTAC linker that can be used to synthesize PROTACs.
-
CCTA-1523
CCTA-1523 is an efflux function of ABCG2 inhibitor. CCTA-1523 selectively reverses ABCG2-mediated MDR in cancer cells.
-
Halazone
Stable, but may be light sensitive. Incompatible with strong oxidizing agents.